Just Healthcare

Just Healthcare

Centanafadine Shows Clinically Meaningful Benefits for Adult ADHD

Triple reuptake inhibitor offers a new non-stimulant option across adults, children, and adolescents

Naveen Sankar S's avatar
Naveen Sankar S
Sep 19, 2025
∙ Paid
Share
Generated image

Centanafadine, a novel norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI),

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture